Skip to content

Muscle activation of abnormal coupling of shoulder and elbow torques during reaching after stroke

Muscle activation of abnormal coupling of shoulder and elbow torques during reaching after stroke - Muscle activation during synergistic arm movements after stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30163
Enrollment
20
Registered
2006-06-13
Start date
2006-12-12
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovascular accident stroke

Interventions

None listed

Sponsors

Revalidatiecentrum Het Roessingh
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: For both stoke patients and healthy subjects: -Aged between 25 and 75 years For stroke patients only: -Stroke at least 6 months prior to admittance to experiment -Right upper extremity affected (due to experimental set-up only for right arm) -Score of 0 or 1 on item AIII-2 of Fugl-Meyer assessment: = anteflexion of the arm from 0° to 90° with full extension of the elbow and the lower arm midway between pro-/supination; performance must be without elbow flexion immediately at the start of movement -Having (received) treatment at the Roessingh Centre of Rehabilitation

Exclusion criteria

Exclusion criteria: For both patients and healthy volunteers: -Shoulder pain, either in rest or in movement -Additional neurologic, orthopaedic or rheumatologic disease of right upper extremity, likely to interfere with mobility and/or strength of the arm -Inability to understand and follow instructions

Design outcomes

Primary

MeasureTime frame
The intensity of activation of 8 shoulder and elbow muscles is measured (by surface EMG), to quantify movement control, along with kinematic parameters (such as velocity and smoothness of movement), to quantify movement execution.

Secondary

MeasureTime frame
(not applicable)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)